Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -336,506 | -105,025 | -418,780 | -296,799 | -248,655 |
| Depreciation Amortization | 19,149 | 10,669 | 37,915 | 27,872 | 17,377 |
| Accounts receivable | -50,864 | -25,204 | -51,650 | -48,447 | -26,180 |
| Other Working Capital | 1,937 | -43,517 | -98,166 | -144,061 | -27,115 |
| Other Operating Activity | 198,294 | 61,902 | 87,509 | 47,589 | -4,944 |
| Operating Cash Flow | $-167,990 | $-101,175 | $-443,172 | $-413,846 | $-289,517 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,060,451 | -779,770 | 436,012 | 466,000 | 406,011 |
| PPE Investments | -14,629 | -5,551 | -38,490 | -36,284 | -27,043 |
| Purchase Of Investment | N/A | N/A | -1,800 | -29,988 | N/A |
| Purchase Sale Intangibles | 0 | N/A | 99,691 | 102,000 | 102,000 |
| Other Investing Activity | -718 | -486 | 99,691 | 98,262 | 98,757 |
| Investing Cash Flow | $-1,075,798 | $-785,807 | $495,413 | $497,990 | $477,725 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,329 | 4,990 | 569,334 | 18,654 | 12,752 |
| Other Financing Activity | 0 | 0 | -7,765 | -6,333 | -6,333 |
| Financing Cash Flow | $5,329 | $4,990 | $561,569 | $12,321 | $6,419 |
| Beginning Cash Position | 2,125,523 | 2,125,523 | 1,511,713 | 1,511,713 | 1,511,713 |
| End Cash Position | 887,064 | 1,243,531 | 2,125,523 | 1,608,178 | 1,706,340 |
| Net Cash Flow | $-1,238,459 | $-881,992 | $613,810 | $96,465 | $194,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -167,990 | -101,175 | -443,172 | -413,846 | -289,517 |
| Capital Expenditure | -14,629 | -5,551 | -38,490 | -36,284 | -27,043 |
| Free Cash Flow | -182,619 | -106,726 | -481,662 | -450,130 | -316,560 |